EDGAR Filing Documents for 0001437749-23-016196

Form 8-K - Current report:

SEC Accession No. 0001437749-23-016196

Filing Date

2023-05-31

Accepted

2023-05-31 08:02:51

Documents

Period of Report

2023-05-25

Items

Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	pbla20230530_8k.htm iXBRL	8-K	61492
2	EXHIBIT 3.1	ex_527861.htm	EX-3.1	9020
3	EXHIBIT 3.2	ex_527862.htm	EX-3.2	9016
4	EXHIBIT 99.1	ex_527828.htm	EX-99.1	12125
9		ex_527828img001.jpg	GRAPHIC	5289
	Complete submission text file	0001437749-23-016196.txt		252050

Data Files

Seq	Description	Document	Type	Size
5	XBRL TAXONOMY EXTENSION SCHEMA	pbla-20230525.xsd	EX-101.SCH	3601
6	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	pbla-20230525_def.xml	EX-101.DEF	11916
7	XBRL TAXONOMY EXTENSION LABEL LINKBASE	pbla-20230525_lab.xml	EX-101.LAB	15956
8	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	pbla-20230525_pre.xml	EX-101.PRE	12127
11	EXTRACTED XBRL INSTANCE DOCUMENT	pbla20230530_8k_htm.xml	XML	2648

Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387

Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196

Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)